Napa Parinyanitikul

Bangkok, 10330, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Transdermal Delivery of Sonidegib via Iontophoresis from PEDOT:PSS/Gelatin Hydrogels for Basal Cell Carcinoma Skin Cancer.

Transdermal Delivery of Sonidegib via Iontophoresis from PEDOT:PSS/Gelatin Hydrogels for Basal Cell Carcinoma Skin Cancer.

Journal: Pharmaceutics

Published: March 05, 2026

Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.

Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.

Journal: Frontiers in oncology

Published: February 10, 2026

The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma.

The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 22, 2025

Feasibility and Preliminary Effectiveness of the ChulaCancer Mobile Chatbot for Supportive Care of Patients With Breast or Colorectal Cancer Receiving Chemotherapy: Pilot Randomized Controlled Trial.

Feasibility and Preliminary Effectiveness of the ChulaCancer Mobile Chatbot for Supportive Care of Patients With Breast or Colorectal Cancer Receiving Chemotherapy: Pilot Randomized Controlled Trial.

Journal: JMIR formative research

Published: November 20, 2025

Skin Barrier Dysfunction, Antimicrobial Peptide Alterations, and Microbiome Changes in Solid Cancer Patients Treated with Epidermal Growth Factor Receptor Inhibitors.

Skin Barrier Dysfunction, Antimicrobial Peptide Alterations, and Microbiome Changes in Solid Cancer Patients Treated with Epidermal Growth Factor Receptor Inhibitors.

Journal: Dermatology (Basel, Switzerland)

Published: August 24, 2025

Clinical Outcomes of HER2-Low Versus HER2-Zero in HR-Positive Metastatic Breast Cancer Treated With Endocrine Therapy With or Without CDK4/6 Inhibitors: A Multicenter Retrospective Study.

Clinical Outcomes of HER2-Low Versus HER2-Zero in HR-Positive Metastatic Breast Cancer Treated With Endocrine Therapy With or Without CDK4/6 Inhibitors: A Multicenter Retrospective Study.

Journal: International journal of breast cancer

Published: July 22, 2025

Electrochemical immunosensor based on poly(5-aminoindole) for cancer biomarker pentraxin-3 detection.

Electrochemical immunosensor based on poly(5-aminoindole) for cancer biomarker pentraxin-3 detection.

Journal: Mikrochimica acta

Published: February 23, 2025

Highly Sensitive Label-Free Immunosensor based on 5-Sulfosalicylic Acid Doped Poly(2-chloroaniline) for Detection of CA72-4 in Gastric Cancer.

Highly Sensitive Label-Free Immunosensor based on 5-Sulfosalicylic Acid Doped Poly(2-chloroaniline) for Detection of CA72-4 in Gastric Cancer.

Journal: Bioelectrochemistry (Amsterdam, Netherlands)

Published: January 20, 2025

Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.

Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.

Journal: Frontiers in oncology

Published: October 08, 2024

Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment.

Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment.

Journal: Frontiers in oncology

Published: October 08, 2024

Comparative effectiveness analysis of survival with first-line palbociclib or ribociclib plus AI in HR + /HER2- advanced breast cancer (CEPRA study): preliminary analysis of real-world data from Thailand.

Comparative effectiveness analysis of survival with first-line palbociclib or ribociclib plus AI in HR + /HER2- advanced breast cancer (CEPRA study): preliminary analysis of real-world data from Thailand.

Journal: BMC cancer

Published: June 21, 2024

Genomic medicine and cancer clinical trial in Thailand.

Genomic medicine and cancer clinical trial in Thailand.

Journal: Cancer biology & medicine

Published: August 24, 2023

Showing 1-12 of 31

Last Updated: 09/26/2026